openPR Logo

Press Releases from DelveInsight Business Research LLP (4789 total)

Bronchitis Pipeline Appears Robust With 15+ Key Pharma Companies Actively Workin …

DelveInsight's, "Bronchitis Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Bronchitis pipeline landscape. It covers the Bronchitis Pipeline

Asthma Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in …

DelveInsight's, "Asthma Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers the Asthma pipeline

Non-Muscle Invasive Bladder Cancer Market: Epidemiology, Therapies, Companies, D …

Non-Muscle Invasive Bladder Cancer therapies are expected to boost the Non-Muscle Invasive Bladder Cancer Market in the upcoming years. DelveInsight has launched a new report on

Nontuberculous Mycobacterial Infections Market: Epidemiology, Therapies, Compani …

Nontuberculous Mycobacterial Infections therapies, such as ARIKAYCE (amikacin liposome inhalation suspension), Epetraborole, MNKD-101 (Clofazimine Inhalation Suspension), SPR720 (Fobrepodacin), and others, are expected to boost the

Cough in Idiopathic Pulmonary Fibrosis Market: Epidemiology, Therapies, Companie …

Cough in Idiopathic Pulmonary Fibrosis therapies, such as Orvepitant Maleate, Haduvio (nalbuphine ER), and others, are expected to boost the Cough in Idiopathic Pulmonary Fibrosis

Diamond Blackfan Anemia Market: Epidemiology, Therapies, Companies, DelveInsight …

Diamond Blackfan Anemia therapies are expected to boost the Diamond Blackfan Anemia Market in the upcoming years. DelveInsight has launched a new report on "Diamond Blackfan

Myelofibrosis Market: Epidemiology, Therapies, Companies, DelveInsight | Abbvie, …

Myelofibrosis therapies, such as JAKAFI/JAKAVI (ruxolitinib), INREBIC (fedratinib), XPOVIO (selinexor), RYTELO (imetelstat), REBLOZYL (luspatercept/ACE-536), and others, are expected to boost the Myelofibrosis Market in the

Cholangiocarcinoma Clinical Trials Appears Robust With 55+ Key Pharma Companies …

DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline

Diabetic Macular Edema Clinical Trials Appears Robust With 45+ Key Pharma Compan …

DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It

Crohn's Disease Clinical Trials Appears Robust With 90+ Key Pharma Companies Act …

DelveInsight's, "Crohn's Disease Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the

Acute Pain Clinical Trials Appears Robust With 25+ Key Pharma Companies Actively …

DelveInsight's, "Acute Pain Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Acute Pain pipeline landscape. It covers the

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Market: Epidemiology, Th …

Metastatic Castration-Resistant Prostate Cancer (mCRPC) therapies, such as JEVTANA (Cabazitaxel), XOFIGO (radium-223), Opevesostat (MK-5684; ODM-208), TRUQAP (capivasertib, AZD 5363), and others, are expected to boost

Mydriasis Market: Epidemiology, Therapies, Companies, DelveInsight | Théa Labo …

Mydriasis therapies, such as RYZUMVI (Phentolamine Ophthalmic Solution 0.75%), MYDCOMBI, OMIDRIA, and others, are expected to boost the Mydriasis Market in the upcoming years. DelveInsight has

Immune Thrombocytopenic Purpura Pipeline 2025: Groundbreaking Clinical Advanceme …

With Immune Thrombocytopenic Purpura reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a

Focal Segmental Glomerulosclerosis Market: Epidemiology, Therapies, Companies, D …

Focal Segmental Glomerulosclerosis therapies, such as LEQVIO (Inclisiran), Olpasiran (AMG 890), and others, are expected to boost the Focal Segmental Glomerulosclerosis Market in the upcoming

Merkel Cell Carcinoma Market: Epidemiology, Therapies, Companies, DelveInsight | …

Merkel Cell Carcinoma therapies, such as Pembrolizumab (MK-3475), ITI-3000, Retifanlimab, KRT-232, Nivolumab, Avelumab, atezolizumab,, and others, are expected to boost the Merkel Cell Carcinoma Market

Spinal Cord Injury Therapeutics Market Size in 7MM is expected to grow at a dece …

DelveInsight's "Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of SCI, historical and forecasted epidemiology, as well

Interleukin-2 Clinical Trials Appears Robust With 8+ Key Pharma Companies Active …

DelveInsight's, "Interleukin-2 (IL-2) Inhibitor Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10 pipeline drugs in Interleukin-2 (IL-2) Inhibitor pipeline landscape. It

Ocular Melanoma Therapeutics Market Size in 7MM is expected to grow at a decent …

DelveInsight's latest report, "Ocular Melanoma Market Insight, Epidemiology And Market Forecast - 2034", combines robust epidemiological data with ocular melanoma market trends, competitive landscape analysis,

Parainfluenza Virus Infection Therapeutics Market Size in 7MM is expected to gro …

DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology as

Postherpetic Neuralgia Therapeutics Market Size in 7MM is expected to grow at a …

(Albany, USA) DelveInsight's "Postherpetic Neuralgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Postherpetic Neuralgia, historical and forecasted epidemiology as

ER+/ HER2 -ve Breast Cancer Clinical Trials Appears Robust With 20+ Key Pharma C …

DelveInsight's, "ER positive, HER2 negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in ER positive, HER2

Mastocytosis Clinical Trials Appears Robust With 10+ Key Pharma Companies Active …

DelveInsight's, "Mastocytosis Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Mastocytosis pipeline landscape. It covers the Mastocytosis pipeline

Hidradenitis Suppurativa Clinical Trials Appears Robust With 24+ Key Pharma Comp …

DelveInsight's, "Hidradenitis Suppurativa Pipeline Insight 2025" report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the

Cutaneous Squamous Cell Carcinoma Clinical Trials Appears Robust With 45+ Key Ph …

DelveInsight's, "Cutaneous Squamous Cell Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline

Cutaneous Lupus Erythematosus Clinical Trials Appears Robust With 10+ Key Pharma …

DelveInsight's, "Cutaneous Lupus Erythematosus Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It

Nephrotic Syndrome Treatment Market Size in the 7MM is expected to increase at a …

DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Nephrotic Syndrome, historical and forecasted epidemiology, and the Nephrotic

Mild Cognitive Impairment Treatment Market Size of the 7MM was ~USD 2,836 millio …

DelveInsight's "Mild Cognitive Impairment Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Mild Cognitive Impairment, historical and forecasted

Intermediate AMD Therapeutics Market Size in the 7MM was ~USD 990 million in 202 …

(openPR) - DelveInsight's "Intermediate AMD Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of intermediate AMD, historical and forecasted epidemiology

Intermediate AMD Therapeutics Market Size in the 7MM was ~USD 990 million in 202 …

DelveInsight's "Intermediate AMD Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of intermediate AMD, historical and forecasted epidemiology as well

Hypophosphatasia Therapeutics Market Size in the 7MM was ~USD 997 million in 202 …

DelveInsight's "Hypophosphatasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Hypophosphatasia, historical and forecasted epidemiology as well as the Hypophosphatasia

Glioblastoma Multiforme Market Size in the 7MM was ~USD 835 million in 2023 and …

DelveInsight's "Glioblastoma Multiforme Market Insight, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of GBM, historical and forecasted epidemiology as well as the GBM

Dry AMD Treatment Market Size in 7MM is expected to grow at a decent CAGR by 203 …

DelveInsight's "Dry AMD Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Dry AMD, historical and forecasted epidemiology as well as

Chronic Kidney Disease Market: Epidemiology, Therapies, Companies, DelveInsight …

Chronic Kidney Disease therapies, such as Ocedurenone (KBP-5074), BI 690517 + Empagliflozin, and others, are expected to boost the Chronic Kidney Disease Market in the

Cervical Cancer Market: Epidemiology, Therapies, Companies, DelveInsight | ADC t …

Cervical Cancer therapies, such as Volrustomig, PRGN-2009, and others, are expected to boost the Cervical Cancer Market in the upcoming years. DelveInsight has launched a new

Axial spondyloarthritis Market: Epidemiology, Therapies, Companies, DelveInsight …

Axial spondyloarthritis therapies, such as SIMPONI (golimumab), XELJANZ (tofacitinib), CIMZIA (certolizumab pegol), ENBREL (Etanercept), RINVOQ (Upadacitinib), COSENTYX (secukinumab), TALTZ (Ixekizumab), LUMICEF (brodalumab), BIMZELX (bimekizumab), and

Atypical Hemolytic Uremic Syndrome Market: Epidemiology, Therapies, Companies, D …

Atypical Hemolytic Uremic Syndrome therapies, such as Crovalimab (RG6107; SKY59), FABHALTA (iptacopan), and others, are expected to boost the Atypical Hemolytic Uremic Syndrome Market in

Amyotrophic Lateral Sclerosis Market: Epidemiology, Therapies, Companies, DelveI …

Amyotrophic Lateral Sclerosis therapies, such as Masitinib, NurOwn (MSC-NTF cells), and others, are expected to boost the Amyotrophic Lateral Sclerosis Market in the upcoming years. DelveInsight

Alzheimer's Disease Market: Epidemiology, Therapies, Companies, DelveInsight | A …

Alzheimer's Disease therapies, such as AR1001, AGB101, AMX0035, IVL3003, BHV-8000, and others, are expected to boost the Alzheimer's Disease Market in the upcoming years. DelveInsight has

Acute Respiratory Distress Syndrome Market: Epidemiology, Therapies, Companies, …

Acute Respiratory Distress Syndrome therapies, such as Sabizabulin (Veru-111), ExoFlo (DB-001), and others, are expected to boost the Acute Respiratory Distress Syndrome Market in the

Acute Kidney Injury Market: Epidemiology, Therapies, Companies, DelveInsight | A …

Acute Kidney Injury therapies, such as RBT-1, OCE-205, and others, are expected to boost the Acute Kidney Injury Market in the upcoming years. DelveInsight has launched

Anemia Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2 …

DelveInsight's "Anemia Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Anemia, historical and forecasted epidemiology as well as the

Balloon Catheter Market to Witness Upsurge in Growth by 2030, Assesses DelveInsi …

DelveInsight's Balloon Catheter Market Insights report provides the current and forecast market analysis, individual leading Balloon Catheter Companies market shares, challenges, Balloon Catheter Market Drivers,

Rheumatoid Arthritis Therapeutics Market Size in 7MM is expected to grow at a de …

DelveInsight's "Rheumatoid Arthritis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of rheumatoid arthritis, historical and forecasted epidemiology as well

Wound Closure Devices Market to Witness Upsurge in Growth by 2030, Assesses Delv …

DelveInsight's Wound Closure Devices Market Insights Report provides the current and forecast market analysis, individual leading Wound Closure Devices Companies market shares, challenges, Wound Closure

Obsessive Compulsive Disorder Therapeutics Market Size in 7MM is expected to gro …

DelveInsight's "Obsessive Compulsive Disorder Treatment Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Obsessive Compulsive Disorder, historical and

Thyroid Eye Disease Therapeutics Market Size in 7MM is expected to grow at a dec …

DelveInsight's "Thyroid Eye Disease Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Thyroid Eye Disease, historical and forecasted

Chemotherapy-induced Nausea and Vomiting Therapeutics Market Size in 7MM is expe …

DelveInsight's "Chemotherapy-Induced Nausea and Vomiting Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chemotherapy-Induced Nausea and Vomiting, historical and forecasted

Ductal Carcinoma in Situ Therapeutics Market Size in 7MM is expected to grow at …

DelveInsight's "Ductal Carcinoma in Situ Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Ductal Carcinoma in Situ, historical and forecasted

NK Cell Lymphoma Therapeutics Market Size in 7MM is expected to grow at a decent …

DelveInsight's "NK Cell Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the NK Cell Lymphoma, historical and forecasted epidemiology as

Go To Page:    1 2 3 4 5 6 7 8 9 10 61 62 63 64 65 66 67 68 69 70